Radiotherapy reduces recurrence of atypical meningiomas, study finds

An international clinical trial, known as ROAM/EORTC-1308, has provided evidence that radiotherapy following the complete surgical resection of atypical meningiomas significantly reduces the risk of tumor recurrence. The study, published in The Lancet, involved 157 patients across 58 hospitals in eleven countries.

Results showed that after a median follow-up of approximately five years, only 14 per cent of patients in the radiotherapy group experienced a recurrence, compared to 30 per cent in the group receiving regular imaging surveillance. Additionally, the disease-free survival rate was 79.9 per cent for the radiotherapy group, versus 64.3 per cent for those under observation.

The research, which included contributions from the Medical University of Vienna, The Walton Centre NHS Foundation Trust, and the University of Liverpool, is expected to be incorporated into national and international clinical guidelines for treating these specific brain tumors.